1. Home
  2. VIAV vs PCVX Comparison

VIAV vs PCVX Comparison

Compare VIAV & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viavi Solutions Inc.

VIAV

Viavi Solutions Inc.

HOLD

Current Price

$50.08

Market Cap

7.7B

Sector

Technology

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$49.12

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIAV
PCVX
Founded
1923
2013
Country
United States
United States
Employees
N/A
507
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7B
7.8B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
VIAV
PCVX
Price
$50.08
$49.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
4
Target Price
$32.66
$88.25
AVG Volume (30 Days)
6.0M
1.4M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
225.00
N/A
EPS
N/A
N/A
Revenue
$1,084,300,000.00
N/A
Revenue This Year
$37.78
N/A
Revenue Next Year
$10.64
N/A
P/E Ratio
N/A
N/A
Revenue Growth
8.39
N/A
52 Week Low
$8.87
$29.10
52 Week High
$60.43
$65.00

Technical Indicators

Market Signals
Indicator
VIAV
PCVX
Relative Strength Index (RSI) 54.63 30.01
Support Level $14.73 $48.49
Resistance Level $60.43 $49.46
Average True Range (ATR) 4.00 2.64
MACD -0.60 -0.68
Stochastic Oscillator 38.80 5.46

Price Performance

Historical Comparison
VIAV
PCVX

About VIAV Viavi Solutions Inc.

Viavi Solutions Inc. is an international provider of network test, monitoring, and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense, and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of its revenue from the United States. Additionally, it manufactures and sells optical filters for 3D sensing products that allow facial recognition security authentication for mobile devices.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

Share on Social Networks: